Emergence of new diseases, lengthy development process, heightened regulatory requirements… all around the world, Virbac is faced with these significant challenges. In this context, innovation is a key driver of the company in formulating the medicines of tomorrow and strengthening the effectiveness of today’s products.
Above all, Virbac innovation is guided by research into satisfying the current or emerging needs of veterinarians, farmers and animal owners (improving the diagnosis and treatment of animal diseases, facilitating veterinary practice). For example, by analyzing expectations using focus groups, Virbac teams seek to identify the most suitable solutions while taking into account changes in societal and regulatory trends: the rise in prevention products, restrictions on the use of antibiotics, new parasiticide molecules…
Virbac’s technological expertise, especially with regard to formulation or biological techniques, gives it the ability to develop medicines and vaccines with strong added value.
In veterinary medicine, unlike with human health, innovation does not come as a result of basic research alone. This is why Virbac has always directed its investment and the work of R&D teams towards applied research and development, encouraging synergies between field teams and researchers.
In addition to innovation resulting from worldwide R&D teams, Virbac regularly develops external partnerships with universities, public or private research laboratories, as well as biotechnology companies. Thanks to alliances with other companies, Virbac also pursues an active commercial and technological business development policy, a source of future innovative R&D projects.
With highly responsive industrial facilities and production plants on all five continents, Virbac is able to produce and market a broad range of products that meet the highest international standards. To secure its supplies, maintain a high level of quality throughout the production chain and guarantee the safety of its products, the Group also relies on a network of suppliers and contract manufacturers selected according to stringent criteria.